Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
Authors:
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 68 (6) , 823-827
Abstract
Objective: To examine the association of radiographic progression and disease activity states in patients with rheumatoid arthritis (RA) treated with methotrexate with or without infliximab. Methods: Patients (n = 1049) with active RA for 3 years or less and no previous methotrexate treatment were randomly assigned (4 : 5 : 5) to receive methotrexate plus placebo or methotrexate plus infliximab 3 or 6 mg/kg at weeks 0, 2 and 6, and every 8 weeks thereafter to week 46. Disease activity was classified by the simplified disease activity index as remission (⩽3.3), low (>3.3 to ⩽11), moderate (>11 to ⩽26), high (>26). Radiographic progression was measured as a change from baseline to week 54 in total Sharp score. Results: At weeks 14 and 54, more patients receiving methotrexate plus infliximab than methotrexate plus placebo were in remission (10.7% versus 2.8% week 14; 21.3% versus 12.3% week 54; pConclusion: With methotrexate, joint damage progresses even at low and moderate disease activity levels, whereas methotrexate plus infliximab inhibits radiographic progression across all disease activity states.Keywords
This publication has 22 references indexed in Scilit:
- The use of TNF-α blocking agents in rheumatoid arthritis: an updateExpert Opinion on Pharmacotherapy, 2007
- Assessing remission in clinical practiceRheumatology, 2007
- Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomesArthritis & Rheumatism, 2006
- Measuring function in rheumatoid arthritis: Identifying reversible and irreversible componentsArthritis & Rheumatism, 2006
- The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a surveyRheumatology, 2006
- Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO resultsAnnals of the Rheumatic Diseases, 2005
- Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?Annals of the Rheumatic Diseases, 2005
- Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity statesArthritis & Rheumatism, 2005
- Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuationAnnals of the Rheumatic Diseases, 1997
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995